YI
111, Inc.
Price Chart
Latest Quote
$3.00
+0.00 (+0.00%)
Current Price
| Previous Close | $3.00 |
| Open | $2.95 |
| Day High | $3.08 |
| Day Low | $2.92 |
| Volume | 16,187 |
Stock Information
Note: Financial values converted from CNY to USD
| Shares Outstanding | 5.20M |
| Total Debt | $42.31M |
| Cash Equivalents | $53.30M |
| Revenue | $1.57B |
| Net Income | $-15.81M |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Market Cap | $26.39M |
| P/E Ratio | 0.29 |
| EPS (TTM) | $10.26 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $888.92M |
| Sales | $1.57B |
| Income | $-15.81M |
| Book/sh | $-13.17 |
| Cash/sh | $68.36 |
| Employees | 1K |
Financial Ratios
| Quick Ratio | 0.38 |
| Current Ratio | 1.07 |
| Debt/Eq | 176.80 |
Returns & Margins
| ROA | -1.34% |
| ROE | -27.53% |
| Gross Margin | 3.00% |
| Operating Margin | -1.01% |
| Profit Margin | -1.00% |
Ownership
| Insider Ownership | 28.56% |
| Institutional Ownership | 0.67% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 21.43 |
| P/S | 0.00 |
| P/B | -0.23 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $3.13 |
| SMA50 | $3.35 |
| SMA200 | $5.09 |
| RSI | 37.70 |
| ATR | 0.1293 |
| Shares Float | 4.66M |
| Short Float | 0.08% |
| Short Ratio | 0.27 |
| Volatility | 0.67 |
| Rel Volume | 1.32 |
Performance History
| Week | -4.15% |
| Month | -14.77% |
| Quarter | -15.73% |
| 6 Months | -54.20% |
| YTD | +8.70% |
| Year | -33.04% |
| 3 Years | +35.14% |
| 5 Years | -48.28% |
| 10 Years | -78.26% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $3.00 | 16,200 |
| 2026-10-26 | $3.00 | 11,300 |
| 2026-10-23 | $2.86 | 15,200 |
| 2026-10-22 | $3.07 | 14,400 |
| 2026-10-21 | $3.15 | 6,400 |
| 2026-10-20 | $3.13 | 9,400 |
| 2026-10-19 | $3.14 | 7,400 |
| 2026-10-16 | $3.13 | 11,800 |
| 2026-10-15 | $3.09 | 24,600 |
| 2026-10-14 | $3.11 | 900 |
| 2026-10-13 | $3.10 | 33,800 |
| 2026-10-12 | $3.11 | 5,200 |
| 2026-10-09 | $3.15 | 6,100 |
| 2026-10-08 | $3.14 | 3,000 |
| 2026-10-07 | $3.15 | 18,800 |
| 2026-10-06 | $3.09 | 12,800 |
| 2026-10-05 | $3.15 | 4,500 |
| 2026-10-02 | $3.22 | 15,500 |
| 2026-10-01 | $3.31 | 9,700 |
| 2026-09-30 | $3.43 | 17,900 |
| 2026-09-29 | $3.50 | 10,500 |
| 2026-09-28 | $3.52 | 18,000 |
About 111, Inc.
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services. It also provides 1 Pharmacy online wholesale pharmacy that offers pharmaceutical and other health and wellness products; and 1 Medicine Marketplace online retail pharmacy that provides drugs, nutritional supplements, medical supplies and devices, personal care, and baby products. In addition, the company offers online loan application services; cloud-based inventory management services; smart procurement services, which collect pharmacies' historical purchase orders and inventory data; and Hawkeye automated salesforce tool, as well as online consultation, e-prescription, and data services. Further, its pharmacies provide drugs, including prescription and over-the-counter drugs comprising Western and Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices that consists of bandages and thermometers; and personal care products that include skin care, birth control, sexual wellness, and baby products. Additionally, the company offers research and development, and consulting services; warehousing, procurement, and logistics services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies, medical professionals, and marketplace sellers. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
đ° Latest News
No news articles available at the moment. Check back later for updates on YI.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,776,776,066 | $2,037,963,394 | $2,117,116,953 | $1,903,526,181 |
| Cost Of Revenue | $1,776,776,066 | $2,037,963,394 | $2,117,116,953 | $1,903,526,181 |
| Total Revenue | $1,885,402,118 | $2,162,479,741 | $2,244,598,793 | $2,029,656,288 |
| Operating Revenue | $1,885,402,118 | $2,162,479,741 | $2,244,598,793 | $2,029,656,288 |
| Expenses | ||||
| Interest Expense | $5,341,462 | $4,254,160 | $3,024,356 | $2,018,590 |
| Total Expenses | $1,885,759,046 | $2,162,162,304 | $2,297,169,072 | $2,085,365,494 |
| Other Income Expense | $1,736,140 | $-225,839 | $1,234,609 | $38,591 |
| Other Non Operating Income Expenses | $1,664,064 | $-89,345 | $1,143,012 | $1,221,094 |
| Net Non Operating Interest Income Expense | $-4,758,094 | $-3,196,889 | $-1,697,850 | $-799,598 |
| Interest Expense Non Operating | $5,341,462 | $4,254,160 | $3,024,356 | $2,018,590 |
| Operating Expense | $108,982,980 | $124,198,910 | $180,052,119 | $181,839,313 |
| Other Operating Expenses | $59,715,453 | $66,417,057 | $79,056,706 | $82,208,247 |
| Selling And Marketing Expense | $38,837,621 | $47,134,516 | $67,329,424 | $68,754,885 |
| General And Administrative Expense | $10,429,906 | $10,647,337 | $33,665,988 | $30,876,181 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-9,969,368 | $-9,721,756 | $-58,966,459 | $-62,598,059 |
| Net Interest Income | $-4,758,094 | $-3,196,889 | $-1,697,850 | $-799,598 |
| Interest Income | $583,368 | $1,057,271 | $1,326,506 | $1,218,992 |
| Normalized Income | $-10,041,445 | $-9,585,261 | $-59,035,157 | $-61,415,555 |
| Net Income From Continuing And Discontinued Operation | $-9,969,368 | $-9,721,756 | $-58,966,459 | $-62,598,059 |
| Total Operating Income As Reported | $-356,928 | $317,437 | $-52,570,278 | $-55,709,206 |
| Net Income Common Stockholders | $-9,969,368 | $-9,721,756 | $-58,966,459 | $-62,598,059 |
| Net Income | $-9,969,368 | $-9,721,756 | $-58,966,459 | $-62,598,059 |
| Net Income Including Noncontrolling Interests | $-3,380,834 | $-3,119,707 | $-53,071,209 | $-56,470,213 |
| Net Income Continuous Operations | $-3,380,834 | $-3,119,707 | $-53,071,209 | $-56,470,213 |
| Pretax Income | $-3,378,882 | $-3,105,292 | $-53,033,520 | $-56,470,213 |
| Interest Income Non Operating | $583,368 | $1,057,271 | $1,326,506 | $1,218,992 |
| Operating Income | $-356,928 | $317,437 | $-52,570,278 | $-55,709,206 |
| Gross Profit | $108,626,052 | $124,516,347 | $127,481,840 | $126,130,107 |
| Per Share | ||||
| Diluted EPS | $-22.82 | $-1.14 | $-7.00 | $-7.51 |
| Basic EPS | $-22.82 | $-1.14 | $-7.00 | $-7.51 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $22,899 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $3,668,389 | $3,833,113 | $-46,830,294 | $-47,139,772 |
| Total Unusual Items | $72,076 | $-136,495 | $91,597 | $-1,182,504 |
| Total Unusual Items Excluding Goodwill | $72,076 | $-136,495 | $91,597 | $-1,182,504 |
| Reconciled Depreciation | $1,777,885 | $2,547,751 | $3,270,467 | $6,129,348 |
| EBITDA (Bullshit earnings) | $3,740,465 | $3,696,619 | $-46,738,697 | $-48,322,275 |
| EBIT | $1,962,580 | $1,148,868 | $-50,009,163 | $-54,451,623 |
| Diluted Average Shares | $1,306,583 | $1,290,135 | $1,265,910 | $1,251,082 |
| Basic Average Shares | $1,306,583 | $1,290,135 | $1,265,910 | $1,251,082 |
| Diluted NI Availto Com Stockholders | $-9,969,368 | $-9,721,756 | $-58,966,459 | $-62,598,059 |
| Minority Interests | $-6,588,534 | $-6,602,049 | $-5,895,249 | $-6,127,846 |
| Tax Provision | $1,952 | $14,415 | $37,690 | $0 |
| Gain On Sale Of Security | $72,076 | $-136,495 | $91,597 | $-1,182,504 |
| Selling General And Administration | $49,267,527 | $57,781,853 | $100,995,413 | $99,631,066 |
| Other Gand A | $10,429,906 | $10,647,337 | $33,665,988 | $30,876,181 |
Fetched: 2026-10-23
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-105,577,220 | $-96,714,675 | $-87,949,283 | $-62,746,416 |
| Total Assets | $330,386,535 | $418,606,254 | $463,847,113 | $521,625,062 |
| Total Non Current Assets | $11,319,449 | $20,735,932 | $23,380,535 | $35,736,233 |
| Other Non Current Assets | $1,394,228 | $2,204,637 | $1,998,619 | $3,055,439 |
| Goodwill And Other Intangible Assets | $130,338 | $215,779 | $338,759 | $490,570 |
| Current Assets | $319,067,085 | $397,870,322 | $440,466,578 | $485,888,829 |
| Other Current Assets | $2,503,454 | $1,017,328 | $1,411,947 | $1,127,545 |
| Restricted Cash | $7,558,563 | $8,415,371 | $3,006,938 | $6,475,164 |
| Prepaid Assets | $9,528,801 | $15,980,841 | $8,157,548 | $12,973,753 |
| Inventory | $149,928,686 | $208,331,297 | $213,135,339 | $225,073,595 |
| Receivables | $65,308,582 | $94,708,548 | $116,600,856 | $108,169,268 |
| Other Receivables | $11,237,463 | $12,456,605 | $16,188,811 | $20,500,182 |
| Taxes Receivable | $6,275,002 | $8,384,438 | $8,151,091 | $7,753,319 |
| Notes Receivable | $8,801,881 | $11,836,598 | $11,652,052 | $6,506,698 |
| Accounts Receivable | $38,994,237 | $62,030,907 | $80,608,901 | $73,409,069 |
| Allowance For Doubtful Accounts Receivable | $-954,262 | $-483,963 | $-642,982 | $-545,078 |
| Gross Accounts Receivable | $39,948,498 | $62,514,870 | $81,251,883 | $73,954,147 |
| Cash Cash Equivalents And Short Term Investments | $84,239,000 | $69,416,937 | $98,153,951 | $132,069,504 |
| Cash And Cash Equivalents | $76,726,386 | $69,416,937 | $90,624,519 | $101,157,585 |
| Debt | ||||
| Total Debt | $35,544,630 | $38,556,373 | $66,554,903 | $51,683,739 |
| Long Term Debt And Capital Lease Obligation | $4,499,520 | $8,326,026 | $9,403,568 | $15,086,343 |
| Current Debt And Capital Lease Obligation | $31,045,110 | $30,230,346 | $57,151,335 | $36,597,396 |
| Current Debt | $28,174,517 | $24,172,775 | $50,765,065 | $26,876,992 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $298,189,253 | $361,431,344 | $422,387,563 | $424,286,626 |
| Total Non Current Liabilities Net Minority Interest | $4,827,017 | $9,671,603 | $10,191,153 | $15,086,343 |
| Other Non Current Liabilities | $327,497 | $1,345,576 | $787,585 | - |
| Current Liabilities | $293,362,236 | $351,759,742 | $412,196,409 | $409,200,283 |
| Other Current Liabilities | $6,916,782 | $13,588,955 | $32,795,366 | $28,610,880 |
| Current Deferred Liabilities | $21,576,673 | $27,910,387 | $23,049,284 | $48,587,306 |
| Payables And Accrued Expenses | $233,823,671 | $280,030,053 | $299,200,425 | $295,404,701 |
| Payables | $226,578,340 | $271,344,996 | $287,466,236 | $283,391,666 |
| Other Payable | $33,591,059 | $12,223,107 | $47,866,542 | $12,717,431 |
| Total Tax Payable | $427,954 | $634,122 | $1,042,856 | $5,665,956 |
| Accounts Payable | $192,559,327 | $258,487,766 | $238,556,838 | $265,008,279 |
| Equity | ||||
| Common Stock Equity | $-105,446,882 | $-96,498,896 | $-87,610,524 | $-62,255,846 |
| Total Equity Gross Minority Interest | $32,197,282 | $57,174,910 | $41,459,550 | $97,338,436 |
| Stockholders Equity | $-105,446,882 | $-96,498,896 | $-87,610,524 | $-62,255,846 |
| Gains Losses Not Affecting Retained Earnings | $10,906,812 | $11,165,386 | $10,888,643 | $11,349,932 |
| Other Equity Adjustments | $10,906,812 | $11,165,386 | $10,888,643 | $11,349,932 |
| Retained Earnings | $-593,186,422 | $-583,217,054 | $-573,495,298 | $-514,528,839 |
| Other | ||||
| Treasury Shares Number | $50,003 | $50,003 | $50,003 | $349,964 |
| Ordinary Shares Number | $26,383,313 | $25,959,168 | $25,683,859 | $25,081,782 |
| Share Issued | $26,433,316 | $26,009,171 | $25,733,862 | $25,431,746 |
| Tangible Book Value | $-105,577,220 | $-96,714,675 | $-87,949,283 | $-62,746,416 |
| Invested Capital | $-77,272,365 | $-72,326,121 | $-36,845,459 | $-35,378,854 |
| Working Capital | $25,704,849 | $46,110,581 | $28,270,169 | $76,688,546 |
| Capital Lease Obligations | $7,370,113 | $14,383,598 | $15,789,838 | $24,806,747 |
| Total Capitalization | $-105,446,882 | $-96,498,896 | $-87,610,524 | $-62,255,846 |
| Minority Interest | $137,644,163 | $153,673,806 | $129,070,074 | $159,594,282 |
| Treasury Stock | $883,987 | $883,987 | $883,987 | $6,135,354 |
| Additional Paid In Capital | $477,707,856 | $476,428,049 | $475,871,560 | $447,050,007 |
| Capital Stock | $8,859 | $8,709 | $8,559 | $8,409 |
| Common Stock | $8,859 | $8,709 | $8,559 | $8,409 |
| Long Term Capital Lease Obligation | $4,499,520 | $8,326,026 | $9,403,568 | $15,086,343 |
| Current Deferred Revenue | $21,576,673 | $27,910,387 | $23,049,284 | $48,587,306 |
| Current Capital Lease Obligation | $2,870,593 | $6,057,571 | $6,386,270 | $9,720,404 |
| Line Of Credit | $28,174,517 | $24,172,775 | $50,765,065 | $26,876,992 |
| Current Accrued Expenses | $7,245,331 | $8,685,057 | $11,734,189 | $12,013,035 |
| Net PPE | $9,794,883 | $18,315,516 | $20,742,839 | $31,889,906 |
| Accumulated Depreciation | $-12,040,214 | $-11,892,006 | $-20,368,192 | $-17,628,688 |
| Gross PPE | $21,835,097 | $30,207,522 | $41,111,031 | $49,518,593 |
| Other Properties | $15,209,774 | $16,832,694 | $41,111,031 | $24,910,957 |
| Buildings And Improvements | $6,625,323 | $13,374,828 | $15,586,373 | $24,607,636 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $149,928,686 | $208,331,297 | $213,135,339 | $225,073,595 |
| Other Short Term Investments | $7,512,614 | $0 | $7,529,432 | $30,911,919 |
| Investments And Advances | - | $0 | $300,318 | $300,318 |
| Leases | - | - | - | - |
| Construction In Progress | - | - | - | - |
| Machinery Furniture Equipment | - | - | - | - |
Fetched: 2026-10-23
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $17,221,907 | $37,211,998 | $-68,633,106 | $-8,234,729 |
| Operating Activities | ||||
| Operating Cash Flow | $17,890,265 | $39,494,267 | $-67,157,792 | $-3,476,485 |
| Cash Flow From Continuing Operating Activities | $17,890,265 | $39,494,267 | $-67,157,792 | $-3,476,485 |
| Operating Gains Losses | $-172,833 | $166,827 | $-363,836 | $758,454 |
| Investing Activities | ||||
| Capital Expenditure | $-668,359 | $-2,282,269 | $-1,475,314 | $-4,758,244 |
| Investing Cash Flow | $-8,067,002 | $5,612,350 | $22,785,604 | $-7,083,459 |
| Cash Flow From Continuing Investing Activities | $-8,067,002 | $5,612,350 | $22,785,604 | $-7,083,459 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $111,869 | $2,102 | $33,485 | $41,144 |
| Financing Cash Flow | $-3,182,474 | $-61,000,065 | $30,929,488 | $3,413,869 |
| Cash Flow From Continuing Financing Activities | $-3,182,474 | $-61,000,065 | $30,929,488 | $3,413,869 |
| Net Other Financing Charges | $-7,296,084 | $-34,409,877 | $5,442,820 | $15,485,766 |
| Net Common Stock Issuance | $111,869 | $2,102 | $33,485 | $41,144 |
| Common Stock Issuance | $111,869 | $2,102 | $33,485 | $41,144 |
| Repurchase Of Capital Stock | - | - | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $-39,188,693 | $-92,491,748 | $-112,638,455 | $-130,461,449 |
| Issuance Of Debt | $43,190,435 | $65,899,458 | $138,091,637 | $118,348,408 |
| Interest Paid Supplemental Data | $362,935 | $924,530 | $1,565,109 | $1,433,870 |
| Income Tax Paid Supplemental Data | $1,952 | $14,415 | $37,690 | $0 |
| End Cash Position | $84,284,948 | $77,832,308 | $93,631,456 | $107,632,749 |
| Beginning Cash Position | $77,832,308 | $93,631,456 | $107,632,749 | $114,221,884 |
| Effect Of Exchange Rate Changes | $-188,149 | $94,300 | $-558,592 | $556,940 |
| Changes In Cash | $6,640,790 | $-15,893,448 | $-13,442,700 | $-7,146,075 |
| Net Issuance Payments Of Debt | $4,001,742 | $-26,592,290 | $25,453,182 | $-12,113,041 |
| Net Short Term Debt Issuance | $4,001,742 | $-26,592,290 | $25,453,182 | $-12,113,041 |
| Short Term Debt Payments | $-39,188,693 | $-92,491,748 | $-112,638,455 | $-130,461,449 |
| Short Term Debt Issuance | $43,190,435 | $65,899,458 | $138,091,637 | $118,348,408 |
| Net Investment Purchase And Sale | $-7,410,956 | $7,825,846 | $24,013,456 | $-2,058,983 |
| Sale Of Investment | $105,208,279 | $76,899,069 | $161,307,898 | $188,481,755 |
| Purchase Of Investment | $-112,619,235 | $-69,073,223 | $-137,294,442 | $-190,540,737 |
| Net Intangibles Purchase And Sale | $0 | $0 | $-450 | $-17,118 |
| Purchase Of Intangibles | $0 | $0 | $-450 | $-17,118 |
| Net PPE Purchase And Sale | $-656,045 | $-2,213,496 | $-1,227,401 | $-4,563,187 |
| Sale Of PPE | $12,313 | $68,773 | $247,462 | $177,939 |
| Purchase Of PPE | $-668,359 | $-2,282,269 | $-1,474,863 | $-4,741,126 |
| Change In Working Capital | $11,597,094 | $28,929,968 | $-63,716,895 | $6,676,678 |
| Change In Other Working Capital | $-1,018,079 | $557,841 | $787,585 | $-230,795 |
| Change In Other Current Liabilities | $298,516 | $-5,117,725 | $-9,384,498 | $-9,838,580 |
| Change In Other Current Assets | $810,259 | $-206,018 | $1,056,820 | $260,977 |
| Change In Payables And Accrued Expense | $-80,434,417 | $15,096,253 | $-61,071,240 | $89,365,885 |
| Change In Accrued Expense | $-14,505,977 | $-4,834,975 | $-34,532,857 | $26,674,877 |
| Change In Payable | $-65,928,439 | $19,931,229 | $-26,538,383 | $62,691,007 |
| Change In Account Payable | $-65,928,439 | $19,931,229 | $-26,538,383 | $62,691,007 |
| Change In Prepaid Assets | $8,172,864 | $-3,936,273 | $8,583,850 | $-5,929,936 |
| Change In Inventory | $58,131,274 | $4,220,524 | $8,948,586 | $-61,008,323 |
| Change In Receivables | $25,636,677 | $18,315,366 | $-12,637,997 | $-5,942,550 |
| Changes In Account Receivables | $22,601,960 | $18,500,061 | $-7,492,643 | $-13,060,395 |
| Other Non Cash Items | $5,811,310 | $7,282,270 | $9,401,466 | $10,409,335 |
| Stock Based Compensation | $1,508,649 | $3,025,557 | $34,039,735 | $24,336,148 |
| Provisionand Write Offof Assets | $477,656 | $77,933 | $292,810 | $404,529 |
| Asset Impairment Charge | $271,338 | $583,669 | $2,989,669 | $4,279,236 |
| Depreciation Amortization Depletion | $1,777,885 | $2,547,751 | $3,270,467 | $6,129,348 |
| Depreciation And Amortization | $1,777,885 | $2,547,751 | $3,270,467 | $6,129,348 |
| Amortization Cash Flow | $85,290 | $122,380 | $151,811 | $260,977 |
| Amortization Of Intangibles | $85,290 | $122,380 | $151,811 | $260,977 |
| Depreciation | $1,692,594 | $2,425,371 | $3,118,656 | $5,868,371 |
| Gain Loss On Investment Securities | $-106,613 | $25,527 | $-604,391 | $-632,771 |
| Net Foreign Currency Exchange Gain Loss | $-72,076 | $136,645 | $91,597 | $1,182,504 |
| Gain Loss On Sale Of PPE | $5,856 | $4,655 | $148,958 | $208,721 |
| Net Income From Continuing Operations | $-3,380,834 | $-3,119,707 | $-53,071,209 | $-56,470,213 |
| Net Business Purchase And Sale | - | $0 | $0 | $-444,171 |
| Purchase Of Business | - | $0 | $0 | $-444,171 |
| Common Stock Payments | - | - | $0 | $0 |
| Net Long Term Debt Issuance | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |
| Earnings Losses From Equity Investments | - | - | - | - |
Fetched: 2026-10-23